Cochrane Review Group
Pain, Palliative and Supportive Care
147 systematic reviews in Pain, Palliative and Supportive Care ask 1,751 questions. 20.6% have no studies to answer them, 35.7% rest on very low certainty evidence and 17.7% reach moderate or high certainty.
Reviews
147
Questions
1,751
current versions
No studies
20.6%
Moderate or high
17.7%
No studies 361 · 20.6%Ungraded 87 · 5%Very low 625 · 35.7%Low 367 · 21%Moderate 232 · 13.2%High 79 · 4.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Summary of findings table ‐ Gabapentin vs pregabalin Risk for at least one adverse event per patient · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | RR 4.7 [0.21, 104.14] | 2 studies · 122 participants | Very low |
Summary of findings table ‐ Kappa‐opioid agonists vs placebo Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Kappa‐opioid agonists vs placebo Patient satisfaction ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Kappa‐opioid agonists vs placebo Depression ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Ondansetron vs placebo Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Ondansetron vs placebo Patient satisfaction ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Ondansetron vs placebo Depression ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ GABA‐analogues vs placebo Quality of life ‐ not measured · health problem or population Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Ondansetron vs placebo Risk for at least one adverse event per patient · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | RR 2.54 [0.38, 16.78] | 3 studies · 174 participants | Very low |
Summary of findings table ‐ Montelukast vs placebo Pruritus · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | 2 studies · 87 participants | Very low |
Summary of findings table ‐ Montelukast vs placebo Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Montelukast vs placebo Patient satisfaction ‐ not measured · patients with chronic kidney disease (CKD) pruritus Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 147
Pharmacological interventions for pruritus in adult palliative care patients
CochraneSoF table
61 questions
Ibuprofen for acute postoperative pain in children
CochraneSoF table
24 questions
Medically assisted hydration for adults receiving palliative care
CochraneSoF table
6 questions
Non‐pharmacological management of infant and young child procedural pain
CochraneSoF table
15 questions
Interventions for the symptoms and signs resulting from jellyfish stings
CochraneSoF table
14 questions
Physical activity and education about physical activity for chronic musculoskeletal pain in children and adolescents
CochraneSoF table
18 questions
Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer
CochraneSoF table
8 questions
Psychological therapies delivered remotely for the management of chronic pain (excluding headache) in adults
CochraneSoF table
24 questions
Antidepressants for pain management in adults with chronic pain: a network meta‐analysis
CochraneSoF table
30 questions
Cannabis‐based medicines and medical cannabis for adults with cancer pain
CochraneSoF table
7 questions
Diclofenac for acute postoperative pain in children
CochraneSoF table
32 questions
Oxycodone for cancer‐related pain
CochraneSoF table
15 questions
Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with cancer and people receiving palliative care
CochraneSoF table
36 questions
Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II
CochraneSoF table
6 questions
Topical clonidine for neuropathic pain in adults
CochraneSoF table
14 questions
Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting
CochraneSoF table
6 questions
Exercise for cancer cachexia in adults
CochraneSoF table
14 questions
Hydromorphone for cancer pain
CochraneSoF table
21 questions
Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta‐analysis
CochraneSoF table
36 questions
Single‐dose intravenous ketorolac for acute postoperative pain in adults
CochraneSoF table
12 questions
Single‐dose intravenous ibuprofen for acute postoperative pain in adults
CochraneSoF table
12 questions
Implanted spinal neuromodulation interventions for chronic pain in adults
CochraneSoF table
27 questions
Interventions for palliative symptom control in COVID‐19 patients
CochraneSoF table
9 questions
Drug therapy for delirium in terminally ill adults
CochraneSoF table
40 questions
Psychological therapies for the management of chronic pain (excluding headache) in adults
CochraneSoF table
14 questions